Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
Abstract Although several prognostic factors in nivolumab therapy have been reported in recurrent or metastatic head and neck cancer (RM-HNC) patients, these factors remain controversial. Here, we conducted a multicenter retrospective cohort study to investigate the impact of clinico-hematological f...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/83aafb03d05a4f159e72936107a43a7e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!